Nevro CORP Form 4 insider transactions

D. Keith Grossman, a director of Nevro Corp., reported the disposition of 228,552 shares of common stock due to the merger with Globus Medical, Inc., where each share was converted into the right to receive $5.85 in cash.

Director Sridhar Kosaraju reports the disposal of Nevro Corp. shares due to the merger with Globus Medical, where each share was converted into $5.85 in cash.

Christofer Christoforou, SVP and Chief Operating Officer of Nevro Corp., disposed of 363,765 shares of common stock as a result of the merger with Globus Medical, Inc.

SVP, Chief Operating Officer of Nevro Corp., Christofer Christoforou, reports acquisition of performance stock units and disposition of shares to cover tax obligations.

SVP Kashif Rashid reports acquisition of shares through PSU vesting and disposition of shares to cover tax obligations.

Roderick H. MacLeod, SVP and CFO of Nevro Corp., reports acquisition and disposal of common stock and vesting of Performance Stock Units.

Greg Siller, SVP & Chief Commercial Officer of Nevro Corp, disposed of shares to cover tax obligations arising from restricted stock units.

Director D. Keith Grossman reports a transaction involving Nevro Corp common stock due to tax obligations.

SVP & Chief Commercial Officer of Nevro Corp, Greg Siller, disposed of 11,500 shares of common stock to cover tax obligations related to restricted stock units.

Nevro Corp's CEO, Kevin Thornal, disposed of 27,029 shares of common stock on March 7, 2025, to satisfy tax withholding obligations related to restricted stock units.

Kashif Rashid, SVP at Nevro Corp, reports the disposal of common stock to cover tax obligations related to restricted stock units.

SVP and CFO of Nevro Corp., Roderick H. MacLeod, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.

Christofer Christoforou, SVP and Chief Operating Officer of Nevro Corp., reported disposing of shares to cover tax obligations related to vested restricted stock units.

Christofer Christoforou, SVP and Chief Operating Officer of Nevro Corp., reported the vesting of performance stock units and subsequent stock disposals to cover tax obligations.

Roderick H. MacLeod, SVP and CFO of Nevro Corp, reports acquisition and disposal of common stock and vesting of Performance Stock Units.

Kashif Rashid, SVP at Nevro Corp, reports acquisition and disposal of common stock and vesting of Performance Stock Units.

D. Keith Grossman, a director at Nevro Corp, reported transactions involving common stock and performance stock units, resulting in adjustments to his beneficial ownership.

Nevro Corp.'s CEO, Kevin Thornal, disposed of 6,685 shares of common stock to cover tax obligations related to restricted stock units.

Kashif Rashid, SVP at Nevro Corp, disposed of 527 shares of common stock on January 4, 2025, to cover tax obligations related to restricted stock units.

Director Michael F. DeMane reports acquisition and disposal of Nevro Corp common stock on December 31, 2024.

Director Sridhar Kosaraju acquired 4,233 shares of Nevro Corp common stock in lieu of cash retainer fees on December 31, 2024.

Director Elizabeth Weatherman acquired 5,325 shares of Nevro Corp common stock as part of her quarterly retainer, bringing her total holdings to 86,171 shares.

Nevro Corp's SVP & Chief Commercial Officer, Greg Siller, disposed of 3,072 shares of common stock to cover tax obligations.

SVP and Chief Operating Officer of Nevro Corp., Christofer Christoforou, disposed of 1,319 shares of common stock to cover tax obligations.

Nevro Corp.'s Chief Financial Officer, Roderick H. MacLeod, sold 1,759 shares of common stock to cover tax obligations related to vesting restricted stock units.

A Nevro Corp executive, Kashif Rashid, sold 1,759 shares of common stock to cover tax obligations related to vesting restricted stock units.

D. Keith Grossman, a director at Nevro Corp, sold 928 shares of common stock to cover tax obligations related to restricted stock units.

A Nevro Corp executive, Kashif Rashid, sold 816 shares of common stock to cover tax obligations related to vesting restricted stock units.

Nevro Corp.'s Chief Financial Officer, Roderick H. MacLeod, sold 816 shares of common stock to cover tax obligations related to vesting restricted stock units.

Nevro Corp.'s SVP, Chief Operating Officer, Christofer Christoforou, sold 583 shares of common stock to cover tax obligations related to vesting restricted stock units.